Financials

  • Market Capitalization 2 B
  • Employee 177
  • Founded 2006
  • CEO N/A
  • Website www.immunome.com
  • Headquarter Delaware, United States
  • FIGI BBG00BR93ZG8
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-8.84
Relación precio/flujo de caja
100.55

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
1927
BCRX
BioCryst Pharmaceuticals, Inc. - Common Stock
8.07 USD-3.47%+2.02%-1.47%+23.77%2.06 B USD
1931
RXRX
Recursion Pharmaceuticals, Inc. - Class A Common Stock
3.84 USD-4.24%-14.86%+14.29%-36.32%2.06 B USD
1953
FTRE
Fortrea Holdings Inc. - Common Stock
20.92 USD-0.38%+2.65%+21.56%+116.79%1.99 B USD
1961
PHVS
Pharvaris N.V. - Ordinary Shares
30.02 USD-2.82%-3.07%-23.26%+35.71%1.96 B USD

Noticias